Trends in oral anticoagulant use in Qatar: a 5-year experience
Author:
Funder
Qatar University
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-017-1474-4.pdf
Reference29 articles.
1. Nutescu EA, Shapiro NL, Ibrahim S, West P (2006) Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf 5(3):433–451. doi: 10.1517/14740338.5.3.433
2. Pirmohamed M (2006) Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol 62(5):509–511. doi: 10.1111/j.1365-2125.2006.02806.x
3. Nutescu EA, Spinler SA, Dager WE, Bussey HI (2004) Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management. Pharmacotherapy 24(10Pt2):199S–202S
4. Horton JD, Bushwick BM (1999) Warfarin therapy: evolving strategies in anticoagulation. Am Fam Phys 59(3):635–646
5. Lip GY, Agnelli G (2014) Edoxaban: a focused review of its clinical pharmacology. Eur Heart J 35(28):1844–1855. doi: 10.1093/eurheartj/ehu181
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE;Mediterranean Journal of Hematology and Infectious Diseases;2024-04-30
2. Evaluation of warfarin management in primary health care centers in Qatar: A retrospective cross-sectional analysis of the national dataset;Current Problems in Cardiology;2024-04
3. Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022;Pharmacy & Pharmacology;2024-01-30
4. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data;European Journal of Clinical Pharmacology;2023-10-10
5. Evolving Trends in Consumption of Direct Oral Anticoagulants in 65 Countries/Regions from 2008 to 2019;Drugs;2023-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3